Literature DB >> 34674519

Adverse outcomes in patients with heart failure admitted for COVID‑19 in association with the use of renin-angiotensin‑aldosterone system inhibitors.

Manuel Méndez-Bailón1, Ricardo Gómez-Huelgas2, Luis M Pérez-Belmonte3, Jaime Sanz-Cánovas2, Alejandro Salinas1, Jose Luis Garcia-Klepzig1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34674519     DOI: 10.20452/pamw.16126

Source DB:  PubMed          Journal:  Pol Arch Intern Med        ISSN: 0032-3772


× No keyword cloud information.
  2 in total

1.  [Answer to the "Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure" correspondence].

Authors:  A Salinas-Botrán; L M Pérez-Belmonte; M Méndez-Bailón
Journal:  Rev Clin Esp       Date:  2021-11-20       Impact factor: 3.064

2.  Answer to the "Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure" correspondence.

Authors:  A Salinas-Botrán; L M Pérez-Belmonte; M Méndez-Bailón
Journal:  Rev Clin Esp (Barc)       Date:  2022-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.